Press ReleaseAIMHI_wpuser2024-08-29T11:16:30+00:00

Press Release

Press Release

Nominate a Trailblazing Woman Leader in Oncology for the 2024 AIM-HI Beacon Award!

AIMHI_wpuser2025-02-21T15:59:23+00:00April 2, 2024|Press Release|

AIM-HI Accelerator Fund Celebrates Yiviva’s Milestone Collaboration with AstraZeneca China, Furthering Technology Platforms for Multiple Cancers

AIMHI_wpuser2025-02-21T15:59:23+00:00February 7, 2024|Press Release|

A Father’s Passion and A Nonprofit Leader’s Vision: Funding Life-Saving Research through Impact-Investment and Venture Philanthropy Partnerships

AIMHI_wpuser2025-02-21T15:59:24+00:00November 24, 2023|Press Release|

Highlights from the 2023 Global Summit and Award Ceremonies for Cancer Research & Entrepreneurship

AIMHI_wpuser2025-02-21T15:59:24+00:00November 14, 2023|Press Release|

The AIM-HI Accelerator Fund Recognizes, Honors, and Congratulates Its 2023 Women’s Venture Competition Top Winners

AIMHI_wpuser2025-02-21T15:59:24+00:00October 16, 2023|Press Release|

The AIM-HI Accelerator Fund Recognizes, Honors, and Congratulates Its 2023 Women’s Venture Competition Top Winners

AIMHI_wpuser2025-02-21T15:59:24+00:00October 16, 2023|Press Release|

Previous 234 Next

AIMhi

AIM-HI Accelerator Fund is a 501(c)(3) tax-exempt nonprofit organization.

Tax ID #: 82-4322538

Address:

5515 Security Lane, Suite 1105
Rockville, MD 20852

Email:

info@aim-hiaccelerator.org

Phone:

1-800-321-CURE (2873)

what we do

Copyright © AIM-HI 2025 All Rights Reserved

AIMhi

AIM-HI Accelerator Fund is a 501(c)(3) tax-exempt nonprofit organization.

Tax ID #: 82-4322538

Copyright © AIM-HI 2025 All Rights Reserved